CVS Health Corp (NYSE:CVS)
$ 44.25 0.11 (0.25%) Market Cap: 55.68 Bil Enterprise Value: 128.87 Bil PE Ratio: 11.23 PB Ratio: 0.74 GF Score: 73/100

CVS Health Corp at Raymond James Institutional Investors Conference Transcript

Mar 05, 2024 / 02:50PM GMT
Release Date Price: $73.71 (-0.24%)
John Wilson Ransom
Raymond James & Associates, Inc., Research Division - MD of Equity Research & Director of Healthcare Research

So good morning, everybody. We're very happy to have CVS back after a lengthy absence. I don't think Larry Merlo felt the greatness last time when he was here, so they've boycotted us for about a decade, but we're back. And so obviously, it's great timing, lots of topics de jure. So I'm glad we're doing a fireside chat, because we can kind of go down some alleyways and make Larry nervous over there, but we'll keep it -- we'll stick to the script.

Questions & Answers

John Wilson Ransom
Raymond James & Associates, Inc., Research Division - MD of Equity Research & Director of Healthcare Research

So let's just shoot one of the elephants in the room, news is breaking that the Change Healthcare situation is either has been fixed or is fixed. What's your perspective on that?

Thomas Francis Cowhey
CVS Health Corporation - Executive VP & CFO

So let me just -- so

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot